<SEC-DOCUMENT>0001567619-20-000816-index.html : 20200109
<SEC-HEADER>0001567619-20-000816.hdr.sgml : 20200109
<ACCEPTANCE-DATETIME>20200109162920
ACCESSION NUMBER:		0001567619-20-000816
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20191230
FILED AS OF DATE:		20200109
DATE AS OF CHANGE:		20200109

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			DONG-A ST CO., LTD
		CENTRAL INDEX KEY:			0001799260
		STATE OF INCORPORATION:			M5
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37809
		FILM NUMBER:		20518476

	BUSINESS ADDRESS:	
		STREET 1:		64, CHEONHO-DAERO
		STREET 2:		DONGDAEMUN-GU
		CITY:			SEOUL
		STATE:			M5
		ZIP:			02587
		BUSINESS PHONE:		82-2-920-8184

	MAIL ADDRESS:	
		STREET 1:		64, CHEONHO-DAERO
		STREET 2:		DONGDAEMUN-GU
		CITY:			SEOUL
		STATE:			M5
		ZIP:			02587

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeuroBo Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		P.O. BOX 130235
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48113
		BUSINESS PHONE:		734-245-1700

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 130235
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
		DATE OF NAME CHANGE:	20150331
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc1.xml
<DESCRIPTION>FORM 3
<TEXT>
Document 1 - file: doc1.html

Document 1 - RAW XML: doc1.xml

</DOCUMENT>
</SEC-DOCUMENT>